 |
[email protected] |
 |
3275638434 |
 |
 |
| Paper Publishing WeChat |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Ganna Lyubartseva1, Sean Parkin2, Shamiso Ngongoni1 and Uma Prasad Mallik
Full-Text PDF
XML 791 Views
DOI:10.17265/1934-7375/2016.05.002
Bis[1-methoxy-2,2,2-tris-(pyrazol-1-yl-κN2)ethane]-copper(II) bis-perchlorate (2) was synthesized by reacting of pyrazole based tripodal scorpionate ligand 1-methoxy-2,2,2-tris(pyrazol-1-yl)ethane (1) with copper(II) perchlorate hexahydrate in methanol, acetonitrile and water mixture as solvent. Slow evaporation of the filtered reaction mixture in air produced blue color block crystals suitable for single crystal X-ray diffraction study of the title complex. Compound 2 crystallizes in the monoclinic space group P21/n with unit cell parameters, a = 8.1269(1) Ả, b = 21.8348(2)Ả, c = 9.1522(1) Å, α = γ = 90º, β = 99.7611(4)º. The structure of the compound was characterized by IR Spectroscopy, elemental analysis and single crystal X-ray diffraction analysis.
Ganna Lyubartseva1, Sean Parkin2, Shamiso Ngongoni1 and Uma Prasad Mallik
[1] Davies, D. T. 1997. Aromatic Heterocyclic Chemistry, 3rd ed. Oxford: Oxford University Press, 28-9.
[2] Keter, K. F., and Darkwa, J. 2012. “Perspective: The Potential of Pyrazole-Based Compounds in Medicine.” Biometals 25: 9-21.
[3] Fustero, S., Sanchez-Rosello, M., Barrio, P., and Simon-Fuentes, A. 2011. “From 2000 to Mid-2010: A Fruitful Decade for the Synthesis of Pyrazoles.” Chem. Rev. 111: 6984-7034.
[4] Azarifar, D., and Shaebanzadeh, M. 2002. “Synthesis and Characterization of New 3,5-Dinaphthyl Substituted 2-Pyrazolines and Study of Their Antimicrobial Activity.” Molecules 7: 885-95.
[5] Amir, M., Kumar, H., and Khan, S. A. 2008. “Synthesis and Pharmacological Evaluation of Pyrazoline Derivatives as New Anti-inflammatory and Analgesic Agents.” Bioorg. Med. Chem. Lett. 18: 918-22.
[6] Sarojini, B. K., Vidyagayatri, M., Darshanraj, C. G., Bharathand B. R., and Manjunatha, H. 2010. “DPPH Scavenging Assay of Novel 1,3-disubstituted-1H-pyrazol-5-ols and Their in Silico Studies on Some Proteins Involved in Alzheimers Disease Signaling Cascade.” Lett. Drug Des. Discovery 7: 214-24.
[7] Regaila, H. A., El-Bayonk, A. K., and Hammad, M. 1979. “Synthesis of Some New Benzimidazole and N-acetyl Pyrazoline Derivatives.” Egypt. J. Chem. 20: 157-66.
[8] Lyubartseva, G., Parkin, S., Coleman, M. D., and Mallik, U. P. 2014. “Crystal Structure of 1-meth¬oxy-2,2,2-tris-(pyrazol-1-yl)ethane.” Acta Cryst. E70: 1047- 8.
[9] Lyubartseva, G., Parkin, S., and Mallik, U. P. 2013. “Bis[1-methoxy-2,2,2-tris(pyrazol-1-yl- N2) ethane]nickel(II) Bis(trifluoromethanesulfonate) Methanol Disolvate.” Acta Cryst. E69: 537.
[10] Lyubartseva, G., Parkin, S., and Mallik, U. P. 2013. Bis[1-methoxy-2,2,2-tris(pyrazol-1-yl- N2) ethane]nickel(II) Bis(trifluoromethanesulfonate) Dehydrate.” Acta Cryst. E69: 532-3.
[11] Lyubartseva, G., Parkin, S., and Mallik, U. P. 2012. Bis[tris(3,5-dimethyl-1H-pyrazol-1-yl- κN2) methyl]sodium Trifluoromethanesulfonate.” Acta Cryst. E68: 973.
[12] Lyubartseva, G., Parkin, S., Mallik, U. P., and Jeon, H. K. 2012. “Tetraethylammonium Tris(thiocyanato- κN) [tris(1H-pyrazol-1-yl-κN2)methane]nickelate(II).” Acta Cryst. E68: 888.
[13] Lyubartseva, G., Parkin, S., and Mallik, U. P. 2011. “Bis[tris(1H-pyrazol-1-yl-κN2)methane] nickel(II) bis{[tris(1H-pyrazol-1-yl κN2)methane]tris(thiocyanato κN)nickelate(II)} Methanol Disolvate.” Acta Cryst. E67: 1656-7.
[14] Lyubartseva, G., and Parkin, S. 2010. “Dichloridobis (3,4,5-trimethyl-1H-pyrazole-κN2) cobalt(II).” Acta Cryst. E66: 1134.
[15] Lyubartseva, G., and Parkin, S. 2010. “Tetraethylammonium (2,2'-bipyridine) tetracyanidocobaltate(III) Sesquihydrate Acetonitrile Solvate.” Acta Cryst. E66: 475-6.
[16] Lyubartseva, G., and Parkin, S. 2009. “Bis (tripyrazol-1-ylmethane)nickel(II) tetracyanidonickelate(II) Dihydrate.” Acta Cryst. E65: 1530.
[17] Maria, L., Cunha, S., Videira, M., Gano, L., Paulo, A., Santos, I. C., and Santos, I. 2007. “Rhenium and Technetium Tricarbonyl Complexes Anchored by Pyrazole-Based Tripods: Novel Lead Structures For the Design of Myocardial Imaging Agents.” Dalton Trans. 3010-9.
[18] Parkin, S., and Hope, H. 1998. “Techniques in Macromolecular Cryocrystallography: Mounting, Archiving and Transportation of Crystals.” J. Appl. Cryst. 31: 945-53.
[19] Sheldrick, G. M. 2008. “A Short History of SHELX.” Acta Cryst. A64: 112-22.
[20] Spek, A. L. 2009. “Structure Validation in Chemical Crystallography.” Acta Cryst. D65: 148-55.
[21] Parkin, S. 2000. “Expansion of Scalar Validation Criteria to Three Dimensions: The R Tensor.” Erratum. Acta Cryst. A56: 157-62.